Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
11 août 2022 08h00 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
01 juin 2022 18h05 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
10 mai 2022 16h01 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
30 mars 2022 07h50 HE | Vyant Bio, Inc.
Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative...
Hope Network Opens Region's Only Comprehensive Autism Treatment Center to Provide Services Under One Roof
19 avr. 2010 09h00 HE | Hope Network
GRAND RAPIDS, MI--(Marketwire - April 19, 2010) -  Hope Network's newest facility, the $1.2 million, 12,000 SF Center for Autism on the Coral Lettinga Campus in Grand Rapids, will officially open...